Bashir MA

References (2)

Title : Neurocognitive Disorders: Systematic Review of Approved (2008-2024) and Pipeline Phase III Medications - Totlani_2025_Innov.Clin.Neurosci_22_57
Author(s) : Totlani J , Bashir MA , Tay L , Ngor A , Steiner AJ , Hirsch D , Contreras L , Renteria S , Danovitch I , Pechnick RN , Ishak WW , Kim S
Ref : Innov Clin Neurosci , 22 :57 , 2025
Abstract :
PubMedSearch : Totlani_2025_Innov.Clin.Neurosci_22_57
PubMedID: 41647067

Title : Synthesis, characterization, molecular docking evaluation, antidepressant, and anti-Alzheimer effects of dibenzylidene ketone derivatives - Bashir_2019_Drug.Dev.Res_80_595
Author(s) : Bashir MA , Khan AU , Badshah H , Rodrigues-Filho E , Din ZU , Khan A
Ref : Drug Dev Res , 80 :595 , 2019
Abstract :
PubMedSearch : Bashir_2019_Drug.Dev.Res_80_595
PubMedID: 30964563